Browsing Tag
HUTCHMED China Limited
2 posts
How China’s lymphoma treatment landscape could evolve with HMPL-760’s registrational study
Can HMPL-760 reshape lymphoma treatment? Explore HUTCHMED’s Phase III strategy and what it means for BTK competition.
Saia, BioNTech, and AppFolio stocks plunge amid trade war fallout
Explore why top U.S. stocks crashed on April 25, 2025, as tariffs, recession risks, and institutional selloffs rattled Wall Street. Read full sector analysis.